Formation and repair of DNA lesions in the p53 gene: Relation to cancer mutations?

Environmental and Molecular Mutagenesis

Volumn 31, Issue 3, 1998, Pages 197-205

  Pfeifer, Gerd P ^a   Denissenko, Mikhail F ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Adducts; Carcinogenesis; Lung cancer; Mutation; p53; Skin cancer

Indexed keywords

BENZO[A]PYRENE; CIGARETTE SMOKE; ENVIRONMENTAL MUTAGEN; PROTEIN P53;

BREAST CANCER; CARCINOGENESIS; COLON CANCER; DNA DAMAGE; DNA REPAIR; HUMAN; LUNG CANCER; MUTATION; REVIEW; SMOKING; SUNLIGHT;

5-METHYLCYTOSINE; ANIMALS; BENZO(A)PYRENE; BREAST NEOPLASMS; CARCINOGENS, ENVIRONMENTAL; COLONIC NEOPLASMS; CYTOSINE; DEAMINATION; DNA ADDUCTS; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA REPAIR; GENES, P53; HUMANS; LUNG NEOPLASMS; MICE; MUTAGENESIS; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; SELECTION (GENETICS); SKIN NEOPLASMS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0031920863     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1998)31:3<197::AID-EM1>3.0.CO;2-I     Document Type: Review

References (92)

1. Aguilar F, Hussain SP, Cerutti P (1993): Aflatoxin B1 induces the transversion of G → T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90:8586-8590.
2. Bailey EA, Iyer RS, Stone MP, Harris TM, Essigman JM (1996): Mutational properties of the primary aflatoxin B1-DNA adduct. Proc Natl Acad Sci USA 93:1535-1539.
3. Barbacid M (1987): ras genes. Annu Rev Biochem 56:779-827.
4. Bargonetti J, Manfredi JJ, Chen X, Marshak DR, Prives C (1993): A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild type but not from oncogenic mutant p53 protein. Genes Dev 7:2565-2574.
5. Beroud C, Verdier F, Soussi T (1996): p53 gene mutation: Software and database. Nucleic Acids Res 24:147-150.
6. Biggs PJ, Warren W, Venitt S, Stratton MR (1993): Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis 8:275-283.
7. Blaszyk H, Hartmann A, Tamura Y, Saitoh S, Cunningham JM, McGovern RM, Schroeder JJ, Schaid DJ, Li K, Monden Y, Morimoto T, Komaki K, Sasa M, Hirata K, Okazaki M, Kovach JS, Sommer SS (1996): Molecular epidemiology of breast cancers in northern and southern Japan: The frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populations. Oncogene 13:2159-2166.
8. Bodner SM, Minna JD, Jensen SM, D' Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar AF, Linnoila RI (1992): Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7:743-749.
9. Brachmann RK, Vidal M, Boeke JD (1996): Dominant-negative p53 mutations selected in yeast hit cancer hotspots. Proc Natl Acad Sci USA 93:4091-4095.
10. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Pontén J (1991): A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128.
11. Brennan J, Boyle J, Koch W, Goodman S, Hruban R, Eby Y, Couch M, Forastiere A, Sidransky D (1995): Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 332:712-717.
12. Bressac B, Kew M, Wands J, Ozturk M (1991): Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431.
13. Caron de Fromentel C, Soussi T (1992): TP53 tumor suppressor gene: A model for investigating human mutagenesis. Genes Chromosomes Cancer 4:1-15.
14. Chen R-H, Maher VM, McCormick JJ (1990): Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (+)-7b,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene. Proc Natl Acad Sci USA 87:8680-8684.
15. Chen R-H, Maher VM, Brouwer J, van de Putte P, McCormick JJ (1992): Preferential repair and strand-specific repair of benzo(a)-pyrene diol epoxide adducts in the HPRT gene of diploid human fibroblasts. Proc Natl Acad Sci USA 89:5413-5417.
16. Cho Y, Gorina S, Jeffrey P, Pavletich NP (1994): Crystal structure of a p53 tumor suppressor-DNA complex: A framework for understanding how mutations inactivate p53. Science 265:346-355.
17. D'Amico D, Carbone D, Mitsudomi T, Nau M, Fedorko J, Russell E, Johnson B, Buchhagen D, Bodner S, Phelps R, Gazdar A, Minna JD (1992): High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene 7:339-346.
18. Denissenko MF, Pao A, Tang M-s, Pfeifer GP (1996): Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274:430-432.
19. Denissenko MF, Chen JX, Tang MS, Pfeifer GP (1997): Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci USA 94:3893-3898.
20. Denissenko MF, Pao A, Pfeifer GP, Tang M-s (1998): Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene (in press).
21. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C, Levine AJ (1993): p53 gain of function mutations. Nat Genet 4:42-46.
22. Douki T, Cadet J (1994): Formation of cyclobutane dimers and (6-4) photoproducts upon far-UV photolysis of 5-methylcytosine-containing dinucleoside monophosphates. Biochemistry 33: 11942-11950.
23. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L (1993): Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 90:10529-10533.
24. Dumaz N, Stary A, Soussi T, Daya-Grosjean L, Sarasin A (1994): Can we predict solar ultraviolet radiation as the causal event in human tumors by analysing the mutation spectra of the p53 gene. Mutat Res 307:375-386.
25. Dumaz N, van Kranen HJ, de Vries A, Berg RJ, Wester PW, van Kreijl CF, Sarasin A, Daya-Grosjean L, de Gruijl FR (1997): The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis 18:897-904.
26. Eisenstadt E, Warren AJ, Porter J, Atkins D, Miller JH (1982): Carcinogenic epoxides of benzo(a)pyrene and cyclopenta(cd)pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci USA 79:1945-1949.
27. Eliyahu D, Raz A, Gruss P, Givol D, Oren M (1984): Participation of p53 cellular tumor antigen in transformation of normal embryonic cells. Nature 312:646-649.
28. Evans MK, Taffe BG, Harris CC, Bohr VA (1993): DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts. Cancer Res 53:5377-5381.
29. Finlay CA, Hinds PW, Levine AJ (1989): The p53 protooncogene can act as a suppressor of transformation. Cell 57:1083-1093.
30. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher IM, Bron L, Benhattar J, Tada M, Van Meir EG, Estreicher A, Iggo R (1995): A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92:3963-3967.
31. Ford JM, Lommel L, Hanawalt PC (1994): Preferential repair of ultraviolet light-induced DNA damage in the transcribed strand of the human p53 gene. Mol Carcinogen 10:105-109.
32. Forrester K, Lupold SE, Ott VL, Chay CH, Band V, Wang XW, Harris CC (1995): Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. Oncogene 10:2103-2111.
33. Friend S (1994): p53: A glimpse at the puppet behind the shadow play. Science 265:334-335.
34. Gao S, Drouin R, Holmquist GP (1994): DNA repair rates mapped along the human PGK-1 gene at nucleotide resolution. Science 263:1438-1440.
35. Gonzalgo ML, Jones PA (1997): Mutagenic and epigenetic effects of DNA methylation. Mutat Res 386:107-118.
36. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994): Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
37. Groopman JD, Scholl P, Wang J-S (1996): Epidemiology of human aflatoxin exposures and their relationship to liver cancer. In Walker C, Groopman J, Slaga TJ, Klein-Szanto A (eds): "Genetics and Cancer Susceptibility: Implications for Risk Assessment." New York: Wiley-Liss, pp 211-222.
38. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC, Montesano R (1997): Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects. Nucleic Acids Res 25:151-157.
39. Halazonetis TD, Kandil AN (1993): Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J 12:5057-5064.
40. Harris CC (1993): p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262:1980-1981.
41. Harris CC (1996): The 1995 Walter Hubert Lecture - Molecular epidemiology of human cancer: Insights from the mutational analysis of the p53 tumour-suppressor gene. Br J Cancer 73:261-269.
42. Hartmann A, Blaszyk H, Kovach JS, Sommer SS (1997): The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet 13:27-33.
43. Harvey M, Vogel H, Morris D, Bradley A, Bernstein A, Donehower LA (1995): A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat Genet 9:305-311.
44. Hecht SS, Carmella SG, Murphy SE, Foiles PG, Chung F-L (1993): Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer. J Cell Biochem Suppl 17F:27-35.
45. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC (1996): Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation. Nucleic Acids Res 24:141-146.
46. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991): Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature 350:427-428.
47. Jelinsky SA, Liu T, Geacintov NE, Loechler EL (1995): The major, N2-Gua adduct of (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G-A and G-C, in addition to G-T mutations. Biochemistry 34:13545-13553.
48. Jiang N, Taylor J-S (1993): In vivo evidence that UV-induced C-T mutations at dipyrimidine sites could result from the replicative bypass of cis-syn cyclobutane dimers or their deamination products. Biochemistry 32:472-481.
49. Jones PA (1996): DNA methylation errors and cancer. Cancer Res 56:2463-2467.
50. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Ferrara P, Mckeon F, Caput D (1997): Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
51. Ko LJ, Prives C (1996): p53: Puzzle and paradigm. Genes Dev 10:1054-1072.
52. Lasky T, Silbergeld E (1996): p53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers. Environ Health Perspect 104:1324-1331.
53. Levine AJ, Wu MC, Chang A, Silver A, Attiyeh EF, Lin J, Epstein CB (1995): The spectrum of mutations at the p53 locus. Ann NY Acad Sci 768:111-128.
54. Lunn RM, Zhang Y-J, Wang L-Y, Chen C-J, Lee P-H, Lee C-S, Tsai W-Y, Santella RM (1997): p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 57:3471-3477.
55. Mazur M, Glickman B (1988): Sequence specificity of mutations induced by benzo(a)pyrene-7,8-diol-9,10-epoxide at endogenous APRT gene in CHO cells. Somat Cell Mol Genet 14:393-400.
56. Mellon I, Spivak G, Hanawalt PC (1987): Selective removal of transcription blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51:241-249.
57. Miller JH (1985): Mutagenic specificty of ultraviolet light. J Mol Biol 182:45-68.
58. Mishimoto Y, Murakami Y, Shiraishi M, Hayashi K, Sekiya T (1992): Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res 52:4799-4804.
59. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD, Gazdar AF (1992): p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
60. Molès JP, Moyret C, Guillot B, Jeanteur P, Guilhou JJ, Theillet C, Basset-Sèguin N (1993): p53 mutations in human epithelial skin cancers. Oncogene 8:583-588.
61. Neddermann P, Gallinari P, Lettieri T, Schmid D, Truong O, Hsuan JJ, Wiebauer K, Jiricny J (1996): Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase. J Biol Chem 271:12767-12774.
62. Ollila J, Lappalainen I, Vihinen M (1996): Sequence specificity in CpG mutation hotspots. FEBS Lett 396:119-122.
63. Olshan AF, Weissler MC, Pei H, Conway K (1997): p53 mutations in head and neck cancer: New data and evaluation of mutational spectra. Cancer Epidemiol Biomarkers Prev 6:499-504.
64. Ory K, Legros Y, Auguin C, Soussi T (1994): Analysis of the most representative tumour-derived p53 mutations reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J 13:3496-3504.
65. Pfeifer GP, Drouin R, Riggs AD, Holmquist GP (1991): In vivo mapping of a DNA adduct at nucleotide resolution: Detection of pyrimidine (6-4) pyrimidone photoproducts by ligation-mediated polymerase chain reaction. Proc Natl Acad Sci USA 88:1374-1378.
66. Pfeifer GP, Drouin R, Riggs AD, Holmquist GP (1992): Binding of transcription factors creates hot spots for UV photoproducts in vivo. Mol Cell Biol 12:1798-1804.
67. Pfeifer GP, Drouin R, Holmquist GP (1993): Detection of DNA adducts at the DNA sequence level by ligation-mediated PCR. Mutat Res 288:39-46.
68. Phillips DH (1996): DNA adducts in human tissues: Biomarkers of exposure to carcinogens in cigarette smoke. Environ Health Perspect 104:453-458.
69. Puisieux A, Lim S, Groopman J, Ozturk M (1991): Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res 51:6185-6189.
70. Rideout WM III. Coetzee GA, Olumi AF, Jones PA (1990): 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249:1288-1290.
71. Rodin SN, Holmquist GP, Rodin AS (1998): CpG transition strand asymmetry and hitch-hiking mutations as measures of tumorigenic selection in shaping the p53 mutational spectrum. Int J Mol Med 1:191-199.
72. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJP (1993): Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc Natl Acad Sci USA 90:1013-1017.
73. Ruzcicska BP, Lemaire DGE (1995): DNA photochemistry In Horspool, WM, Song, P-S (eds). CRC Handbook of Organic Photochemistry and Photobiology." Boca Raton, FL: CRC Press, pp 1289-1317.
74. Schmutte C, Yang AS, Beart RW, Jones PA (1995): Base excision repair of U:G mismatches at a mutational hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors. Cancer Res 55:3742-3746.
75. Setlow RB (1974): The wavelengths in sunlight effective in producing skin cancer: A theoretical analysis. Proc Natl Acad Sci USA 71:3363-3366.
76. Shen H-M, Ong C-N (1996): Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat Res 366:23-44.
77. Sommer SS, Ketterling RP (1996): The factor IX gene as a model for analysis of human germline mutations: An update. Hum Mol Genet 5:1505-1514.
78. Soussi T, May P (1996): Structural aspects of the p53 protein in relation to gene evolution: A second look. J Mol Biol 260:623-637.
79. Strauss BS (1997): Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis 18:1445-1452.
80. Tang M-s, Pierce JR, Doisy RP, Nazimiec ME, MacLeod MC (1992): Differences and similarities in the repair of two benzo[a]pyrene diol epoxide isomers induced DNA adducts by uvrA, uvrB, and uvrC geneproducts. Biochemistry 31:8429-8436.
81. Taylor JA, Li Y, He M, Mason T, Mettlin C, Vogler WJ, Maygarden S, Liu E (1996): p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res 55:294-298.
82. Tommasi S, Denissenko MF, Pfeifer GP (1997): Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res 57:4727-4730.
83. Tornaletti S, Pfeifer GP (1994): Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 263:1436-1438.
84. Tornaletti S, Pfeifer GP (1995): Complete and tissue-independent methylation of CpG sites in the p53 gene: Implications for mutations in human cancers. Oncogene 10:1493-1499.
85. Tornaletti S, Rozek D, Pfeifer GP (1993): The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene 8:2051-2057.
86. Tu Y, Tornaletti S, Pfeifer GP (1996): DNA repair domains within a human gene: Selective repair of sequences near the transcription initiation site. EMBO J 15:675-683.
87. Urbach F (1989): Potential effects of altered solar ultraviolet radiation on human skin cancer. Photochem Photobiol 50:507-513.
88. Vogelstein B, Kinzler KW (1994): X-rays strike p53 again. Nature 370:174-175.
89. Wei D, Maher VM, McCormick JJ (1995): Site-specific rates of excision repair of benzo[a]pyrene diol epoxide adducts in the hypoxanthine phosphoribosyltransferase gene of human fibroblasts: Correlation with mutation spectra. Proc Natl Acad Sci USA 92:2204-2208.
90. Wood RD, Skopek TR, Hutchison F (1984): Changes in DNA base sequence induced by targeted mutagenesis of lambda phage by ultraviolet light. J Mol Biol 173:273-291.
91. Yang AS, Gonzalgo ML, Zingg JM, Millar RP, Buckley JD, Jones PA (1996): The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline. J Mol Biol 258:240-250.
92. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash DE (1993): Mutation hot spots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90:4216-4220.